Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more

Biogen shares rose 0.7% after beating revenue and earnings consensus and raising full-year adjusted EPS guidance.

Likely continued premarket strength and tighter downside range into the open.

The article cites both an earnings beat and a full-year adjusted EPS guidance increase, which typically drives follow-through buying.

Vertiv tumbled 13% despite beating earnings and revenue, because organic revenue growth of 17.8% lagged consensus 23.6%.

Higher probability of continued weakness at the open and elevated volatility.

The article explicitly ties the large drop to a specific organic growth shortfall versus consensus.

GE HealthCare shares were up 12% after adjusted EPS of $1.13 beat consensus $1.04 and full-year guidance was reaffirmed.

Potential for sustained strength through the session if no new negative headlines emerge.

The catalyst is clearly stated as an EPS beat with guidance reaffirmation, which usually limits downside.

Procter & Gamble shares dropped over 3% after quarterly revenue missed expectations, with net income down to $3.04B from $3.62B.

Sustained downside risk at the open, with potential for further selling if traders focus on the miss.

The article cites a clear top-line miss versus forecast and a year-over-year net income decline.

Deutsche Bank rose more than 2% after reporting Q2 after-tax profit of 1.9 billion euros, described as a record for the period.

Moderate upside continuation possible, but likely capped by broader bank-sector sensitivity.

The article highlights a concrete profit datapoint and CFO commentary that all businesses performed well.

General Dynamics shares were up nearly 1% after beating consensus on revenue and EPS, with backlog at $136.5B.

Mild-to-moderate upside bias into the open, with less downside than peers lacking backlog support.

The article provides both the beat and the backlog level, a key defense contractor driver.

Ford surged 6% after beating second-quarter adjusted earnings and hiking its 2026 earnings outlook, despite slightly weaker automotive revenue.

Likely continued strength at the open, though traders may watch for margin and revenue follow-through.

The article explicitly states an earnings beat and an outlook hike, which typically outweighs a small revenue miss.

PPG shares dropped around 1% after EPS and adjusted EBITDA missed estimates, though it reaffirmed full-year EPS guidance.

Choppy trading likely, with bias depending on how investors weigh the miss versus reaffirmation.

The article cites both the miss and the reaffirmed full-year guidance, which often reduces the magnitude of selloffs.